Question 1

What is congenital bile acid synthesis defect 3?

Accepted Answer

Congenital bile acid synthesis defect 3 is a severe liver disorder that presents in the neonatal period with cholestatic liver disease, marked by jaundice, acholic stools, and failure to thrive. It is caused by pathogenic variants in the CYP7B1 gene, which disrupt a critical step in bile acid synthesis. The condition follows an autosomal recessive inheritance pattern, meaning that affected individuals inherit two copies of the altered gene, one from each parent. It is very rare, affecting fewer than 1 in a million people.

Question 2

What are the symptoms of congenital bile acid synthesis defect 3?

Accepted Answer

The clinical presentation is dominated by severe liver-related findings. Affected newborns typically exhibit neonatal cholestasis with persistent jaundice, acholic stools, and failure to thrive. Additional consistent features include hepatomegaly, splenomegaly, and laboratory abnormalities such as elevated alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase levels, as well as prolonged prothrombin time and hyperbilirubinemia. Histologic features seen on liver evaluation include cirrhosis, hepatic bridging fibrosis, bile duct proliferation, and ductal bile plugs, with hematochezia also reported. Not all individuals experience every feature, and severity varies considerably.

Question 3

What causes congenital bile acid synthesis defect 3?

Accepted Answer

This condition is caused by pathogenic variants in the CYP7B1 gene, which encodes an enzyme essential for the synthesis of bile acids. Disruption of this enzyme impairs normal bile acid production, leading to toxic accumulation of intermediates and resulting in severe liver injury. It is inherited in an autosomal recessive pattern, which means that both parents must carry one copy of the variant for an affected child to result. This condition is more common when parents share a common ancestor, as the chance that both carry the same rare genetic variant is increased. Genetic counseling is recommended for families to understand recurrence risks and discuss testing options. Associated genes include CYP7B1.

Question 4

How is congenital bile acid synthesis defect 3 inherited?

Accepted Answer

congenital bile acid synthesis defect 3 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is congenital bile acid synthesis defect 3?

Accepted Answer

congenital bile acid synthesis defect 3 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is congenital bile acid synthesis defect 3 diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in CYP7B1. In addition to genetic testing, clinical evaluation of the characteristic neonatal cholestatic liver disease and supportive laboratory findings such as elevated liver enzymes and abnormal coagulation profiles help to establish the diagnosis. Because many of these features can overlap with other liver disorders, genetic confirmation is essential to distinguish congenital bile acid synthesis defect 3 from other conditions.

Question 7

Are there treatments for congenital bile acid synthesis defect 3?

Accepted Answer

Currently, management focuses on supportive care and symptom management, with treatment tailored to the individual. There are no foundational or targeted therapies specifically approved for this condition, so care is provided by a multidisciplinary team experienced in managing complex liver disorders. Regular surveillance is an essential part of long-term care, with monitoring to detect complications such as progressive liver dysfunction and hepatic failure at an early stage. Patients and families are encouraged to discuss treatment options with their healthcare team and consider genetic counseling to address inheritance concerns and family planning.

Question 8

Are there clinical trials for congenital bile acid synthesis defect 3?

Accepted Answer

Yes, there is currently 1 active clinical trial for congenital bile acid synthesis defect 3 registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What complications can arise from congenital bile acid synthesis defect 3?

Accepted Answer

Congenital bile acid synthesis defect 3 can lead to serious complications like progressive liver dysfunction and hepatic failure. Regular monitoring is essential to catch these issues early. Families should work closely with their healthcare team to manage these risks and ensure the best possible care.

Question 10

How does congenital bile acid synthesis defect 3 affect daily life for patients and families?

Accepted Answer

Living with congenital bile acid synthesis defect 3 often requires careful management of symptoms and regular medical appointments. Families may need to monitor their child's growth and liver health closely. Supportive care is crucial, and having a multidisciplinary team can help make daily life more manageable.

Question 11

What is the prognosis for someone with congenital bile acid synthesis defect 3?

Accepted Answer

The prognosis for congenital bile acid synthesis defect 3 varies based on the severity of liver involvement and how quickly supportive care is provided. With proper management, many individuals can benefit from ongoing care, but the disease can still be challenging. Families are encouraged to connect with specialists for the best outcomes.

Question 12

What specialists should families consult for congenital bile acid synthesis defect 3?

Accepted Answer

Families dealing with congenital bile acid synthesis defect 3 should consult specialists experienced in managing complex liver disorders. A multidisciplinary team can provide comprehensive care, including monitoring for complications and managing symptoms. Genetic counseling is also recommended to discuss inheritance and family planning.

Research Type	Count	% of Total
Laboratory research	5	38%

Kisho

congenital bile acid synthesis defect 3

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

congenital bile acid synthesis defect 3

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital bile acid synthesis defect 3?

What are the symptoms of congenital bile acid synthesis defect 3?

What causes congenital bile acid synthesis defect 3?

How is congenital bile acid synthesis defect 3 inherited?

How rare is congenital bile acid synthesis defect 3?

How is congenital bile acid synthesis defect 3 diagnosed?

Are there treatments for congenital bile acid synthesis defect 3?

Are there clinical trials for congenital bile acid synthesis defect 3?

What complications can arise from congenital bile acid synthesis defect 3?

How does congenital bile acid synthesis defect 3 affect daily life for patients and families?

What is the prognosis for someone with congenital bile acid synthesis defect 3?

What specialists should families consult for congenital bile acid synthesis defect 3?

Explore clinical features

Recent Publications